In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

Working with mouse cells, the researchers developed a highly efficient conversion method that can produce more than 10 ...

A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.

In a ceremony held last month, the 2024 Louisa Gross Horwitz Prize was awarded to Wesley Sundquist, PhD, Leo T. and Barbara K ...

Converting one type of cell to another—for example, a skin cell to a neuron—can be done through a process that requires the ...

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according ...

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study. The discovery could lead ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

We explored this hypothesis in a cnidarian Hydra model system, in which spontaneous tumors can occur in the lab, and lineages in which such neoplastic cells are vertically transmitted (through host ...